Remove 2020 Remove Key account management Remove Patients
article thumbnail

The Imperative for KAM in Pharma

PM360

Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated key account management (KAM) strategies and capabilities to provide unique offerings and value. This leads to fewer health systems treating a larger percentage of total patients each year.

article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

Everything from training field personnel to navigate new tools more efficiently from remote environments, to changing both the offering and its customer platform (HCPs and patients) to create the highest level of value and impact will need renewed strategic attention. Leading Teams in the “New Normal” Environment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical trials in Ukraine: Ensuring supply chain continuity during war

Pharmaceutical Technology

When war broke out in Ukraine in early 2022, many clinical trial patients had to flee the country or relocate, presenting considerable disruption to existing clinical trials and risking data collection on medical products. The situation has tested business continuity plans to their limits. Since then, the numbers have understandably reduced.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. This was higher than the number of approvals in 2019 and 2020. Several drug development trends are driving injectables demand.

Pharma 52